Found this:Extract below, from this url:...

Found this:
Extract below, from this url: http://www.fda.gov/Drugs/NewsEvents/ucm326450.htm

Food
Drugs
-
Impact of Approved Drug Labeling on Chronic Opioid Therapy Part 15 Meeting
The U.S. Food and Drug Administration (FDA) is announcing a public hearing to obtain information, particularly scientific evidence, such as study data or peer-reviewed analyses, on issues pertaining to the use of opioid drugs in the treatment of chronic pain. These issues include: diagnosis and understanding of patient pain, understanding and adhering to the labels of pain-treating products, limiting opioid prescriptions and use, and abuse and misuse of opioid medicines.

Date(s): February 7-8, 2013 from 9:00 a.m. to 4:00 p.m.

Location: Bethesda Marriott
5151 Pooks Hill Road
Bethesda, MD 20814

Federal Register Notice (PDF - 191KB)

Registration: If you wish to attend the workshop or provide oral comments during the open session of the meeting, please register by January 18, 2013.